New drug HWK-007 targets Hard-to-Treat cancers in early trial

NCT ID NCT07444814

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This early-stage study tests a new drug called HWK-007 in people with advanced solid tumors, including certain ovarian, endometrial, and lung cancers. The drug is designed to target a protein (PTK7) found on cancer cells and deliver a chemotherapy-like payload directly to them. The main goals are to find the safest dose and check for side effects. About 226 adults will take part, and the study is currently recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutchinson Cancer Center

    NOT_YET_RECRUITING

    Seattle, Washington, 98109, United States

  • Hackensack University Medical Center - John Theurer Cancer Center

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • NEXT - Oncology - Houston

    RECRUITING

    Houston, Texas, 77054, United States

  • NEXT Oncology - Austin

    RECRUITING

    Austin, Texas, 78758, United States

  • NEXT Oncology - Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Roswell Park Comprehensive Care Center

    RECRUITING

    Buffalo, New York, 14263, United States

  • START - Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • START - San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

  • St. Francis Medical Center (OSF Healthcare)

    RECRUITING

    Peoria, Illinois, 61637, United States

  • UCLA - Hematology/Oncology Clinical Research Unit

    NOT_YET_RECRUITING

    Los Angeles, California, 90095, United States

  • University Hospital - Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University of Arkansas

    RECRUITING

    Little Rock, Arkansas, 72205-7199, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.